Literature DB >> 25354474

A revival for immunoglobulin therapy in septic shock?

Julien Textoris1, Thierry Calandra, Frédéric Pène.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25354474     DOI： 10.1007/s00134-014-3506-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  16 in total

1.  Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome.

Authors:  Pauline Gatterre; Mehdi Oualha; Laurent Dupic; Franck Iserin; Christine Bodemer; Fabrice Lesage; Philippe Hubert
Journal:  Intensive Care Med       Date:  2012-01-25       Impact factor: 17.440

2.  Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity.

Authors:  Jerome P Jayasekera; E Ashley Moseman; Michael C Carroll
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

3.  Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.

Authors:  Agnes Dechartres; Isabelle Boutron; Ludovic Trinquart; Pierre Charles; Philippe Ravaud
Journal:  Ann Intern Med       Date:  2011-07-05       Impact factor: 25.391

4.  Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients.

Authors:  Fabienne Venet; Rémi Gebeile; Julien Bancel; Caroline Guignant; Françoise Poitevin-Later; Christophe Malcus; Alain Lepape; Guillaume Monneret
Journal:  Int Immunopharmacol       Date:  2011-09-13       Impact factor: 4.932

Review 5.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Authors:  Inessa Schwab; Falk Nimmerjahn
Journal:  Nat Rev Immunol       Date:  2013-02-15       Impact factor: 53.106

6.  Association between analytic strategy and estimates of treatment outcomes in meta-analyses.

Authors:  Agnes Dechartres; Douglas G Altman; Ludovic Trinquart; Isabelle Boutron; Philippe Ravaud
Journal:  JAMA       Date:  2014-08-13       Impact factor: 56.272

Review 7.  Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.

Authors:  Marissa M Alejandria; Mary Ann D Lansang; Leonila F Dans; Jacinto Blas Mantaring
Journal:  Cochrane Database Syst Rev       Date:  2013-09-16

8.  Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock.

Authors:  Ilaria Cavazzuti; Giulia Serafini; Stefano Busani; Laura Rinaldi; Emanuela Biagioni; Marta Buoncristiano; Massimo Girardis
Journal:  Intensive Care Med       Date:  2014-09-13       Impact factor: 17.440

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

10.  Identification of residues in the Cmu4 domain of polymeric IgM essential for interaction with Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

Authors:  Ashfaq Ghumra; Jean-Philippe Semblat; Richard S McIntosh; Ahmed Raza; Ingunn B Rasmussen; Ranveig Braathen; Finn-Eirik Johansen; Inger Sandlie; Patricia K Mongini; J Alexandra Rowe; Richard J Pleass
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.